Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
286 results found
2026
Recommendations on pneumococcal vaccination to at-risk groups
Recommendation Europe Sweden Risk group Pneumococcal disease
Download:
2026 ∙ STIKO
Update of the STIKO recommendation on vaccination against pneumococcal disease for children and adolescents with risk factors aged ≥ 2 to 17 years
Recommendation Europe Germany children adolescents Risk group Pneumococcal disease
Download:
2025 ∙ Vink, K. Kusters, J. Wallinga, J.
Chrono-optimizing vaccine administration: a systematic review and meta-analysis
Adults Older adults COVID-19 Influenza Hepatitis B Hepatitis A Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.
Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022
All age groups Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Cao, B. K. Hanifa, R. S. Nguyen, T. P. Postma, M. J. van der Schans, J.
Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review
South-East Asia Western Pacific Adults Older adults Influenza COVID-19 Pneumococcal disease Varicella Pertussis Economic aspects
Rating:
Not applicable
2025 ∙ Dunne, E. M. Hong, L. Althouse, B. M. Hayford, K. Jodar, L. Gessner, B. D. Theilacker, C.
Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Nimpa, M. M. Ntambue, A. Ngandu, C. Danovaro-Holliday, M. C. Bita Fouda, A. Cikomola, A. M. W. Mukendi, J. C. Mwamba, D. Aluma, A. D. L. Yapi, M. D. Nikiema, J. B. Hama Sambo, B. Ishoso, D. K.
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Africa Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Akther, A. Laurie, C. Elton-Marshall, T. Ly, V. Sulis, G.
Healthcare workers' current practices, knowledge/awareness, barriers, and attitudes/perceptions related to pneumococcal vaccination of older adults: A mixed-methods systematic review
All age groups Healthcare workers Pneumococcal disease Acceptance
Rating:
Not applicable
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis
Adults Older adults Pneumococcal disease Influenza COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.
Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Low
Loading...